FDA Grants Conditional Approval To Interventional Spine's PercuDyn" System IDE Application

More good potential news for those with chronic back pain related to degenerative discs. It is not fully FDA approved yet, pending the submittal of additional information, but thus far it looks promising. It is an implanted device and a procedure done in an outpatient setting. It appears numerous units can be placed on the spine, depending on where the problem lies. The devices makes moving a lot less painful. Watch the video at the site for more information. At any rate we all know the risks of surgery on the spine and as of now fusion seems to be what has been the primary choice, but it looks like now there are some new alternatives on the horizon. BD

Interventional Spine, Inc. announced that the U.S. Food and Drug Administration has approved the Company's investigational device exemption (IDE) application for its PercuDyn System for the treatment of degenerative disc disease (DDD). This approval is conditional upon the Company providing some additional information to the FDA.